Becton, Dickinson & Co. (BDX)
188.38
-1.14
(-0.60%)
USD |
NYSE |
Aug 31, 12:39
Becton, Dickinson Free Cash Flow : 2.533B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.533B |
| March 31, 2026 | 3.079B |
| December 31, 2025 | 2.656B |
| September 30, 2025 | 2.695B |
| June 30, 2025 | 2.575B |
| March 31, 2025 | 2.605B |
| December 31, 2024 | 2.936B |
| September 30, 2024 | 3.073B |
| June 30, 2024 | 3.221B |
| March 31, 2024 | 3.026B |
| December 31, 2023 | 2.648B |
| September 30, 2023 | 2.115B |
| June 30, 2023 | 1.742B |
| March 31, 2023 | 1.441B |
| December 31, 2022 | 1.506B |
| September 30, 2022 | 1.661B |
| June 30, 2022 | 1.503B |
| March 31, 2022 | 1.646B |
| December 31, 2021 | 2.513B |
| September 30, 2021 | 3.453B |
| June 30, 2021 | 4.222B |
| March 31, 2021 | 4.15B |
| December 31, 2020 | 3.475B |
| September 30, 2020 | 2.729B |
| June 30, 2020 | 2.474B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.51B |
| December 31, 2019 | 2.835B |
| September 30, 2019 | 2.373B |
| June 30, 2019 | 2.359B |
| March 31, 2019 | 2.008B |
| December 31, 2018 | 1.906B |
| September 30, 2018 | 1.97B |
| June 30, 2018 | 1.837B |
| March 31, 2018 | 1.682B |
| December 31, 2017 | 1.762B |
| September 30, 2017 | 1.823B |
| June 30, 2017 | 1.368B |
| March 31, 2017 | 1.858B |
| December 31, 2016 | 1.723B |
| September 30, 2016 | 1.841B |
| June 30, 2016 | 1.888B |
| March 31, 2016 | 1.603B |
| December 31, 2015 | 1.247B |
| September 30, 2015 | 1.097B |
| June 30, 2015 | 905.00M |
| March 31, 2015 | 816.00M |
| December 31, 2014 | 1.028B |
| September 30, 2014 | 1.093B |
| June 30, 2014 | 1.355B |
| March 31, 2014 | 1.337B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 7.824B |
| Boston Scientific Corp. | 3.625B |
| Stryker Corp. | 4.702B |
| Baxter International, Inc. | 812.00M |
| Intuitive Surgical, Inc. | 3.223B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 652.00M |
| Cash from Investing (Quarterly) | -228.00M |
| Cash from Financing (Quarterly) | -651.00M |
| Free Cash Flow Per Share (Quarterly) | 1.850 |
| Free Cash Flow to Equity (Quarterly) | 980.00M |
| Free Cash Flow to Firm (Quarterly) | 616.70M |
| Free Cash Flow Yield | 4.76% |